A Study to Assess the Efficacy of Erlotinib for Leptomeningeal Carcinomatosis in EGFR Mutation Positive Non-small Cell Lung Cancer

This study has been terminated.
(low accrual rate)
Sponsor:
Collaborators:
Seoul National University Hospital
Korean Cancer Study Group
Information provided by:
Clinical Research Center for Solid Tumor, Korea
ClinicalTrials.gov Identifier:
NCT00830245
First received: January 24, 2009
Last updated: July 25, 2011
Last verified: July 2011
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been terminated.
  Study Completion Date: July 2011
  Primary Completion Date: July 2011 (Final data collection date for primary outcome measure)